ArticleReproductive medicine and biology

The novel oral gonadotropin-releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles.

Shinnosuke Komiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.